Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Leukemia & Lymphoma
|
May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
The Journal of Experimental Medicine
|
May 28, 2017
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression
Eunsun Kim, Ying Cheng, Elisabeth Bolton-Gillespie, et al.
Journal of Cardiovascular Electrophysiology
|
June 15, 2026
Deep Learning-Based Prediction of Heart Failure Readmission Using Longitudinal Cardiac Device Data
Veronica Ramos, Shantanu Sarkar, Jodi Koehler, et al.
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Blood Advances
|
February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Jason Xu, Michael McCoy, Zachary Martinez, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Leukemia & Lymphoma
|
May 2, 2022
A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
Thomas Prebet, Aaron D Goldberg, Joseph G Jurcic, et al.
The Journal of Experimental Medicine
|
May 28, 2017
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression
Eunsun Kim, Ying Cheng, Elisabeth Bolton-Gillespie, et al.
Journal of Cardiovascular Electrophysiology
|
June 15, 2026
Deep Learning-Based Prediction of Heart Failure Readmission Using Longitudinal Cardiac Device Data
Veronica Ramos, Shantanu Sarkar, Jodi Koehler, et al.
Blood Advances
|
December 21, 2021
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Aaron T Gerds, Bart L Scott, Peter Greenberg, et al.
Blood Advances
|
February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia
Jason Xu, Michael McCoy, Zachary Martinez, et al.
Page
of 2